Few stocks have skyrocketed like Axim Biotechnologies (NASDAQOTH:AXIM). Last year, Axim ranked not only as the best marijuana stock in terms of overall performance, but also took the top spot among all biotech stocks.
So far in 2017, though, Axim shareholders have experienced a roller-coaster ride, with the stock more than doubling in price early in the year before giving up most of the gains. In March, shares soared more than 65% but again dropped close to their starting level.